Two KRAS-targeted strategies are starting to reshape treatment for metastatic pancreatic cancer after decades of limited progress with chemotherapy.

Researchers at University of California San Diego have developed a new artificial intelligence (AI) model that can translate ...

Cancer researchers have spent decades cataloging mutations found in tumors, building databases that now hold millions of ...

Not every region of your brain is equally susceptible to cancer. Over many decades of treating brain cancer, doctors have ...

A melanoma cell can dodge a targeted drug in dozens of different ways, each driven by a different genetic mutation. But what ...

KRAS is one of the oncogenes most frequently altered in cancer, mutated in approximately one-third of lung adenocarcinomas.

In clinical trials, the drug was shown to almost double the survival time for pancreatic cancer patients. Here's how it works ...

Scientists say factors that shape the microbiome early in life — including diet, antibiotics, and breastfeeding — may influence cancer risk years later.

When it comes to cancer, tumor suppressor genes are usually thought of as the "good guys." These genes make proteins that ...

Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval. According to the National Cancer ...

Sperm from a single donor in Europe has reportedly been used to conceive at least 67 pregnancies, although the donor carried a rare cancer-causing mutation. The donor’s mutation has been linked to ...

Jackie Tohn, star of “Nobody Wants This” learned she carries a genetic risk for breast cancer after her father’s diagnosis.